Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SCYNEXIS INCSCYX · Entity 7194 | Chief Legal Officer | January 29, 2026 | February 02, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SCYNEXIS INC
Report date January 29, 2026 · Filed February 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 574,539 |
Reported balance
After 2026-01-29 transaction · row 1
1 source rowRow 1 · 2026-01-29 · Grant · Acquired 129,833 · Balance 574,539 F1: Represents restricted stock units that vest one third per year over three years as measured from February 28, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units that vest one third per year over three years as measured from February 28, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 29, 2026 Filed Feb 2, 2026 21:02 UTC | SCYNEXIS INC SCYX · Entity 7194 | GrantCommon Stock | 129,833 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-033583 · ownership.xml · nonDerivative · entry 1 Sukenick Scott · CIK 0001722886 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 574,539 F1 · shares: Represents restricted stock units that vest one third per year over three years as measured from February 28, 2026. Read SEC document |
| January 23, 2025 Filed Jan 27, 2025 21:05 UTC | SCYNEXIS INC SCYX · Entity 7194 | GrantEmployee Stock Option (Right to Buy) · Derivative | 138,767 | $0.00 Strike: $1.08 | $0.00 |
DisclosureSEC source: 0000950170-25-009188 · ownership.xml · derivative · entry 2 Sukenick Scott · CIK 0001722886 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 138,767 Underlying: Common Stock · 138,767 shares Expires 2035-01-22 F2 · derivative.exercise_date: 1/48th of the shares subject to the option vest monthly for 48 months as measured from January 23, 2025. Read SEC document |
| January 23, 2025 Filed Jan 27, 2025 21:05 UTC | SCYNEXIS INC SCYX · Entity 7194 | GrantCommon Stock | 92,511 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-009188 · ownership.xml · nonDerivative · entry 1 Sukenick Scott · CIK 0001722886 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 436,706 F1 · shares: Represents restricted stock units that vest one third per year over three years as measured from February 28, 2025. Read SEC document |
| February 16, 2024 Filed Feb 16, 2024 22:48 UTC | SCYNEXIS INC SCYX · Entity 7194 | Tax withholdingCommon Stock | 15,179 | $1.63 | $24,741.77 |
DisclosureSEC source: 0000950170-24-016578 · ownership.xml · nonDerivative · entry 1 Sukenick Scott · CIK 0001722886 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 336,195 F1 · shares: Represents the number of shares withheld by and surrendered to the Issuer to satisfy tax withholding obligations that arose in connection with a vesting event from a restricted stock unit award. Read SEC document |
| January 26, 2024 Filed Jan 30, 2024 21:01 UTC | SCYNEXIS INC SCYX · Entity 7194 | GrantEmployee Stock Option (Right to Buy) · Derivative | 215,515 | $0.00 Strike: $1.86 | $0.00 |
DisclosureSEC source: 0000950170-24-008802 · ownership.xml · derivative · entry 2 Sukenick Scott · CIK 0001722886 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 215,515 Underlying: Common Stock · 215,515 shares Expires 2034-01-25 F3 · derivative.exercise_date: 1/48th of the shares subject to the option vest monthly for 48 months as measured from February 15, 2024. Read SEC document |
| January 26, 2024 Filed Jan 30, 2024 21:01 UTC | SCYNEXIS INC SCYX · Entity 7194 | GrantCommon Stock | 143,675 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-008802 · ownership.xml · nonDerivative · entry 1 Sukenick Scott · CIK 0001722886 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 351,374 F1 · shares: Represents restricted stock units that vest one third per year over three years as measured from February 15, 2024. F2 · balance_after: Includes 4,100 shares of common stock acquired under the 2014 Employee Stock Purchase Plan in March 2023 (100 shares) and September 2023 (4,000 shares). Read SEC document |
| May 15, 2023 Filed May 17, 2023 20:01 UTC | SCYNEXIS INC SCYX · Entity 7194 | GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-030126 · doc4.xml · nonDerivative · entry 1 Sukenick Scott · CIK 0001722886 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 203,599 F1 · shares: Represent restricted stock units that vest over three years in equal, annual installments. Read SEC document |
| January 27, 2023 Filed Jan 31, 2023 21:01 UTC | SCYNEXIS INC SCYX · Entity 7194 | GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-005675 · doc4.xml · nonDerivative · entry 1 Sukenick Scott · CIK 0001722886 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,599 F1 · shares: Represent restricted stock units that vest over three years in equal, annual installments. F2 · balance_after: Includes 100 shares acquired by the reporting person under the Issuer's 2014 Employee Stock Purchase Plan on September 5, 2022. Read SEC document |
| April 26, 2022 Filed Apr 28, 2022 11:24 UTC | SCYNEXIS INC SCYX · Entity 7194 | GrantCommon Stock Warrant · Derivative | 3,500 | $0.00 Strike: $3.45 | $0.00 |
DisclosureSEC source: 0001209191-22-025902 · doc4.xml · derivative · entry 2 Sukenick Scott · CIK 0001722886 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,500 Underlying: Common Stock · 3,500 shares Expires 2029-04-26 Read SEC document |
| April 26, 2022 Filed Apr 28, 2022 11:24 UTC | SCYNEXIS INC SCYX · Entity 7194 | PurchaseCommon Stock | 3,500 | $3.00 | $10,500.00 |
DisclosureSEC source: 0001209191-22-025902 · doc4.xml · nonDerivative · entry 1 Sukenick Scott · CIK 0001722886 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,499 F1 · price: Reflects the purchase on April 26, 2022, of 3,500 shares of the issuer's common stock, par value $0.001 per share, at a public offering price of $3.00 per share of common stock and accompanying warrant. F2 · balance_after: Includes shares purchased under the issuer's ESPP, which did not require the filing of a Form 4 for such purchase. Read SEC document |
| February 04, 2022 Filed Feb 8, 2022 21:13 UTC | SCYNEXIS INC SCYX · Entity 7194 | GrantStock Option (Right to Buy) · Derivative | 70,000 | $0.00 Strike: $4.60 | $0.00 |
DisclosureSEC source: 0001209191-22-007733 · doc4.xml · derivative · entry 2 Sukenick Scott · CIK 0001722886 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2032-02-03 F2 · derivative.exercise_date: 1/48th of the shares subject to the option vest monthly for 48 months as measured from the date of grant. Read SEC document |
| February 04, 2022 Filed Feb 8, 2022 21:13 UTC | SCYNEXIS INC SCYX · Entity 7194 | GrantCommon Stock | 40,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-007733 · doc4.xml · nonDerivative · entry 1 Sukenick Scott · CIK 0001722886 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,899 F1 · shares: Represents restricted stock units that vest 50% per year over two years on the anniversary of the date of grant. Read SEC document |
| January 29, 2021 Filed Feb 2, 2021 21:02 UTC | SCYNEXIS INC SCYX · Entity 7194 | GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $7.47 | $0.00 |
DisclosureSEC source: 0001209191-21-006717 · doc4.xml · derivative · entry 1 Sukenick Scott · CIK 0001722886 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2031-01-28 F1 · derivative.exercise_date: 1/48th of the shares subject to the option vest monthly for 48 months as measured from the date of grant. Read SEC document |
| December 21, 2020 Filed Dec 23, 2020 14:10 UTC | SCYNEXIS INC SCYX · Entity 7194 | GrantCommon Stock Warrant · Derivative | 800 | Not disclosed Strike: $8.25 | Not disclosed |
DisclosureSEC source: 0001209191-20-064959 · doc4.xml · derivative · entry 3 Sukenick Scott · CIK 0001722886 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 800 Underlying: Common Stock · 800 shares Expires 2024-06-21 F1 · price: Reflects the purchase on December 21, 2020 of 1,600 shares of the issuer's common stock, par value $0.001 per share, at a public offering price of $6.25 per share of common stock and accompanying warrants to purchase 0.50 of a share of common stock (Series 1 warrant) and 0.50 of a share of common stock (Series 2 warrant). Read SEC document |
| December 21, 2020 Filed Dec 23, 2020 14:10 UTC | SCYNEXIS INC SCYX · Entity 7194 | GrantCommon Stock Warrant · Derivative | 800 | Not disclosed Strike: $7.33 | Not disclosed |
DisclosureSEC source: 0001209191-20-064959 · doc4.xml · derivative · entry 2 Sukenick Scott · CIK 0001722886 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 800 Underlying: Common Stock · 800 shares Expires 2021-12-21 F1 · price: Reflects the purchase on December 21, 2020 of 1,600 shares of the issuer's common stock, par value $0.001 per share, at a public offering price of $6.25 per share of common stock and accompanying warrants to purchase 0.50 of a share of common stock (Series 1 warrant) and 0.50 of a share of common stock (Series 2 warrant). Read SEC document |
| December 21, 2020 Filed Dec 23, 2020 14:10 UTC | SCYNEXIS INC SCYX · Entity 7194 | PurchaseCommon Stock | 1,600 | $6.25 | $10,000.00 |
DisclosureSEC source: 0001209191-20-064959 · doc4.xml · nonDerivative · entry 1 Sukenick Scott · CIK 0001722886 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,099 F1 · price: Reflects the purchase on December 21, 2020 of 1,600 shares of the issuer's common stock, par value $0.001 per share, at a public offering price of $6.25 per share of common stock and accompanying warrants to purchase 0.50 of a share of common stock (Series 1 warrant) and 0.50 of a share of common stock (Series 2 warrant). Read SEC document |
| November 25, 2020 Filed Dec 5, 2020 02:00 UTC | SCYNEXIS INC SCYX · Entity 7194 | Tax withholdingCommon Stock | 2,613 | $6.81 | $17,794.53 |
DisclosureSEC source: 0001209191-20-061879 · doc4.xml · nonDerivative · entry 2 Sukenick Scott · CIK 0001722886 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,499 F1 · shares: Represents the number of shares withheld by and surrendered to the Issuer to satisfy tax withholding obligations that arose in connection with a vesting event from a restricted stock unit award. F2 · balance_after: Includes 200 shares acquired in 2020 by the reporting person under the Issuer's 2014 Employee Stock Purchase Plan: 100 shares on March 5, 2020 and 100 shares on September 5, 2020. Read SEC document |
| February 15, 2020 Filed Dec 5, 2020 02:00 UTC | SCYNEXIS INC SCYX · Entity 7194 | Tax withholdingCommon Stock | 783 | $9.80 | $7,673.40 |
DisclosureSEC source: 0001209191-20-061879 · doc4.xml · nonDerivative · entry 1 Sukenick Scott · CIK 0001722886 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,912 F1 · shares: Represents the number of shares withheld by and surrendered to the Issuer to satisfy tax withholding obligations that arose in connection with a vesting event from a restricted stock unit award. Read SEC document |
| January 31, 2020 Filed Feb 4, 2020 21:05 UTC | SCYNEXIS INC SCYX · Entity 7194 | GrantStock Option (Right to Buy) · Derivative | 250,000 | $0.00 Strike: $0.86 | $0.00 |
DisclosureSEC source: 0001209191-20-006274 · doc4.xml · derivative · entry 1 Sukenick Scott · CIK 0001722886 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2030-01-30 F1 · derivative.exercise_date: 1/48th of the shares subject to the option vest monthly for 48 months as measured from the date of grant. Read SEC document |
| February 15, 2019 Filed Feb 19, 2019 21:53 UTC | SCYNEXIS INC SCYX · Entity 7194 | GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $1.38 | $0.00 |
DisclosureSEC source: 0001209191-19-011128 · doc4.xml · derivative · entry 2 Sukenick Scott · CIK 0001722886 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2029-02-14 F2 · derivative.exercise_date: 1/48th of the shares subject to the option vest monthly for 48 months as measured from the date of grant. Read SEC document |
| February 15, 2019 Filed Feb 19, 2019 21:53 UTC | SCYNEXIS INC SCYX · Entity 7194 | GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-011128 · doc4.xml · nonDerivative · entry 1 Sukenick Scott · CIK 0001722886 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,959 F1 · shares: Represents restricted stock units that vest 25% per year over four years. Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 12:51 UTC | SCYNEXIS INC SCYX · Entity 7194 | PurchaseCommon Stock Warrant (right to buy) · Derivative | 1,331 | Not disclosed Strike: $2.00 | Not disclosed |
DisclosureSEC source: 0001209191-18-018709 · doc4.xml · derivative · entry 3 Sukenick Scott · CIK 0001722886 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,331 Underlying: Common Stock · 1,331 shares Expires 2023-03-08 F1 · price: Reflects the purchase on March 8, 2018, of 2,959 shares of the issuer's common stock, par value $0.001 per share, at a public offering price of $1.69 per share of common stock and accompanying warrants to purchase 0.75 of a share of common stock (Series 1 warrant) and 0.45 of a share of common stock (Series 2 warrant). Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 12:51 UTC | SCYNEXIS INC SCYX · Entity 7194 | PurchaseCommon Stock Warrant (right to buy) · Derivative | 2,219 | Not disclosed Strike: $1.85 | Not disclosed |
DisclosureSEC source: 0001209191-18-018709 · doc4.xml · derivative · entry 2 Sukenick Scott · CIK 0001722886 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,219 Underlying: Common Stock · 2,219 shares Expires 2019-03-14 F1 · price: Reflects the purchase on March 8, 2018, of 2,959 shares of the issuer's common stock, par value $0.001 per share, at a public offering price of $1.69 per share of common stock and accompanying warrants to purchase 0.75 of a share of common stock (Series 1 warrant) and 0.45 of a share of common stock (Series 2 warrant). Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 12:51 UTC | SCYNEXIS INC SCYX · Entity 7194 | PurchaseCommon Stock | 2,959 | $1.69 | $5,000.71 |
DisclosureSEC source: 0001209191-18-018709 · doc4.xml · nonDerivative · entry 1 Sukenick Scott · CIK 0001722886 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,959 F1 · price: Reflects the purchase on March 8, 2018, of 2,959 shares of the issuer's common stock, par value $0.001 per share, at a public offering price of $1.69 per share of common stock and accompanying warrants to purchase 0.75 of a share of common stock (Series 1 warrant) and 0.45 of a share of common stock (Series 2 warrant). Read SEC document |
| February 09, 2018 Filed Feb 13, 2018 22:03 UTC | SCYNEXIS INC SCYX · Entity 7194 | GrantStock option (right to buy) · Derivative | 15,000 | $0.00 Strike: $1.69 | $0.00 |
DisclosureSEC source: 0001209191-18-009627 · doc4.xml · derivative · entry 1 Sukenick Scott · CIK 0001722886 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2028-02-08 F1 · derivative.exercise_date: 1/48th of the shares subject to the option vest monthly for 48 months as measured from the date of grant. Read SEC document |
| November 15, 2017 Filed Nov 17, 2017 21:13 UTC | SCYNEXIS INC SCYX · Entity 7194 | GrantStock Option (right to buy) · Derivative | 160,000 | $0.00 Strike: $1.75 | $0.00 |
DisclosureSEC source: 0001209191-17-061447 · doc4.xml · derivative · entry 1 Sukenick Scott · CIK 0001722886 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,000 Underlying: Common Stock · 160,000 shares Expires 2027-11-14 F1 · derivative.exercise_date: 25% of the shares subject to this option vests on the one-year anniversary of the grant date with the remainder vesting in equal monthly installments for thirty-six (36) months thereafter, provided the executive continues to provide continuous services to us. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.